Magellan RBM Unit Posts 44% Profit Growth for Q1

Magellan Health Services reported a 6.3% Q1 year-over-year increase in revenue, with a 24.9% overall segment profit before EBITA. Three of five segments reported growth in profits, including the radiology benefits management segment, with profits of $19,274,000 in Q1 2013 compared to $13,361,000 in Q1 2012, a 44% increase. The RBM segment brought in $90,278,000 in revenue in Q1 2013 compared to $76,857,000 in Q1 2012. Pharmacy solutions, not including dispensing revenue, declined from $60,898,000 in Q1 2012 to $58,150,000 Q1 2013. The company also reported increases in revenue and profit for the commercial and public sector insurance segments: Commercial segment Q1 revenue increased from $180.5 million in 2012 to $187.8 million in 2013; and public sector revenue increased from $388.8 million to $406.6 million. Earnings per share for Q1 2013 year-over-year increased 34.7%. “Magellan had a strong first quarter, with good performance across our businesses,” said Barry M. Smith, chief executive officer, in a press release. “This is an important year as we continue to execute on our Magellan Complete Care and Magellan Pharmacy Solutions initiatives. In each of those areas, we continue to build out our capabilities in order to fuel aggressive growth, and we are seeing traction in the market. “Magellan Complete Care, for example, is well positioned for market entry in Florida, having just completed its review as part of the final regulatory approval process. We expect to begin enrolling members by the third quarter with the ultimate objective of becoming a specialty plan serving Medicaid recipients with Serious Mental Illness. Smith also expressed disappointment about the award of the Maricopa County, Arizona contract to another vendor for the period beginning October 1, 2013, which led to a downward adjustment in guidance for 2013.News Release
Cheryl Proval,

Vice President, Executive Editor, Radiology Business

Cheryl began her career in journalism when Wite-Out was a relatively new technology. During the past 16 years, she has covered radiology and followed developments in healthcare policy. She holds a BA in History from the University of Delaware and likes nothing better than a good story, well told.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.